Oxogluric acid

DB08845InvestigationalNutraceuticalSmall molecule

Oxogluric acid (α-Ketoglutarate) is not approved for any indication in the world but is an investigational drug in the United States. In the United States a phase I clinical trial... Oxogluric acid is sold as a dietary supplement to athletes to improve their performance by helping to remove excess ammonia, but it is not officially approved for this indication and only experimental studies have shown...

Chemical structure of Oxogluric acid
Mechanism
Curator reviewed
Primary indication
α-α-Ketoglutarate is not approved for any indication in the world but is an investigational drug in the United States.Curator reviewed
Formula / weight
C5H6O5 · 146.0981 g/mol (avg)
Also known as
2-Ketoglutaric acid · 2-oxoglutaric acid · 2-oxopentanedioic acid · Alpha-ketoglutarate · alpha-Ketoglutaric acid
Code names
NSC-17391

Resolves to

Clinical / RWD
Structure
InChIKeyKPGXRSRHYNQIFN-UHFFFAOYSA-NSMILESOC(=O)CCC(=O)C(O)=O
Targets

What you can answer from here — as of July 16, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
19Clinical trialsPhase, status and sponsor resolved per trial
Sign in
12Marketed productsAcross 2 countries and 1 labeller
Sign in
4+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Oxogluric acid, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.

Create Account